Cooley, Latham Prep Electra Therapeutics' $325M IPO Plan
By Jade Martinez-Pogue · September 15, 2026, 2:07 PM EDT
Biotechnology firm Electra Therapeutics plans to make its public debut this week through an estimated $325 million initial public offering steered by Cooley LLP and Latham & Watkins LLP....
To view the full article, register now.